explore -WSS

explore

author：fashion 2025-10-01 17:34:36 - browse：18

insulin biosimilar — Last week, the FDA released a trio of guidelines clarifying the way they plan to evaluate devices that go through the 510(k) pathway. Jacquelyn Martin/AP

Five years after promising to fix a flawed regulatory pathway widely used by medical device manufacturers, the Food and Drug Administration has issued new guidelines to improve its so-called 510(k) program that has long been lambasted for letting risky devices fall through the cracks.

Most medical device companies do not have to test their products on people in order to secure clearance from the FDA — they simply have to show they’re “substantially equivalent” to devices already on the market, called “predicates.” This process is the 510(k) pathway, and accounts for the vast majority of new medical devices launched on the market each year. Devices cleared through this pathway include X-ray machines, muscle stimulators, and wheelchairs.

Last week, the FDA released a trio of guidelines clarifying the way it plans to evaluate devices that go through the 510(k) pathway. The agency is asking manufacturers to avoid predicate devices that were recalled due to a “design-related” issue or have “unmitigated” safety concerns. Manufacturers should submit flow charts explaining why they chose their predicate device. If they have to choose one with a recall history or safety issues, they should explain how the new device addresses those problems. The FDA may also ask the manufacturer for clinical data in this case.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Sen. Bill Cassidy on how to lower drug prices

WSS

Solve the antibiotic resistance crisis with preventive drugs

California man arrested in connection with serial murders of Mexican strip club workers

FDA struggles to regulate food additives, sometimes for decades

STAT Summit: Michael J. Fox on progress in Parkinson's research

Senate committee scrutinizes Medicare Advantage brokers

Why health workers in Gaza are injured or die at high rates

entertainment

explore

Wikipedia

Affirmative action in medical school literally saved lives

US intelligence assessment says Iran not currently developing nuclear weapons

Bright Health sells Medicare Advantage business to Molina

How corporate America is slashing DEI workers amid backlash to diversity programs

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Trump seeks lengthy delay of classified docs trial, citing upcoming election

How to save PrEP access — and even expand it

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

Medicare proposal to cover medical devices draws a mixed reaction

NIH confirmation hearing shows politicization of research

knowledge

How redistricting in 6 states could affect who controls Congress

What to know about a major upcoming Wegovy heart health study

California man arrested in connection with serial murders of Mexican strip club workers

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

Rare Northern Lights show in US this week: Where and how to see it

FDA struggles to regulate food additives, sometimes for decades

leisure time

leisure time

knowledge

focus